The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Antagonism between Bacteriostatic and Bactericidal Antibiotics Is Prevalent
Open accessAbstract
Combination therapy is rarely used to counter the evolution of resistance in bacterial infections. Expansion of the use of combination therapy requires knowledge of how drugs interact at inhibitory concentrations. More than 50 years ago, it was noted that, if bactericidal drugs are most potent with actively dividing cells, then the inhibition of growth induced by a bacteriostatic drug should result in an overall reduction of efficacy when the drug is used in combination with a bactericidal drug. Our goal here was to investigate this hypothesis systematically. We first constructed time-kill curves using five different antibiotics at clinically relevant concentrations, and we observed antagonism between bactericidal and bacteriostatic drugs. We extended our investigation by performing a screen of pairwise combinations of 21 different antibiotics at subinhibitory concentrations, and we found that strong antagonistic interactions were enriched significantly among combinations of bacteriostatic and bactericidal drugs. Finally, since our hypothesis relies on phenotypic effects produced by different drug classes, we recreated these experiments in a microfluidic device and performed time-lapse microscopy to directly observe and quantify the growth and division of individual cells with controlled antibiotic concentrations. While our single-cell observations supported the antagonism between bacteriostatic and bactericidal drugs, they revealed an unexpected variety of cellular responses to antagonistic drug combinations, suggesting that multiple mechanisms underlie the interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Gaussian Processes for Machine Learning
Rasmussen, C. E., & Williams, C. K. I. (2005) · doi:10.7551/mitpress/3206.001.0001 · Cited by 11,705
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Wikler, M. A., & Clinical (2006) · Clinical and Laboratory Standards Institute eBooks · Cited by 2,843
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Changing patterns of mortality across Europe in patients infected with HIV-1
Mocroft, A., Vella, S., Benfield, T., Chiesi, A., Miller, V, Gargalianos, P., Monforte, A. D., Yust, I., Bruun, J., Phillips, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03201-2 · Cited by 1,270
Pankey, G. A., & Sabath, L. D. (2004) · Clinical Infectious Diseases · doi:10.1086/381972 · Cited by 1,201
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025
Robust Growth of Escherichia coli
Wang, P., Robert, L., Pelletier, J., Dang, W. L., Taddei, F., Wright, A., & Jun, S. (2010) · Current Biology · doi:10.1016/j.cub.2010.04.045 · Cited by 1,014
(1953) · PubMed · Cited by 942
Topley and Wilson's Principles of bacteriology and immunity
Topley, W. W. C., Miles, A. A., & Wilson, G. S. (1946) · doi:10.5962/bhl.title.7024 · Cited by 710
Evaluating treatment protocols to prevent antibiotic resistance
Bonhoeffer, S., Lipsitch, M., & Levin, B. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12106 · Cited by 487
Self-citationAntibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439
Drug interactions and the evolution of antibiotic resistance
Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2133 · Cited by 350
Functional classification of drugs by properties of their pairwise interactions
Yeh, P., Tschumi, A. I., & Kishony, R. (2006) · Nature Genetics · doi:10.1038/ng1755 · Cited by 350
Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria
Eng, R. H., Padberg, F. T., Smith, S. M., Tan, E. N., & Cherubin, C. E. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1824 · Cited by 350
Bacterial evolution of antibiotic hypersensitivity
Lázár, V., Pal Singh, G., Spohn, R., Nagy, I., Horváth, B., Hrtyan, M., Busa‐Fekete, R., Bogos, B., Méhi, O., Csörgő, B., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.57 · Cited by 350
Self-citationWHO Guidelines for the treatment of malaria
Kunte, R., & Kunwar, R. (2011) · Medical Journal Armed Forces India · doi:10.1016/s0377-1237(16)30022-3 · Cited by 341
Systematic exploration of synergistic drug pairs
Cokol, M., Chua, H. N., Tasan, M., Mutlu, B., Weinstein, Z. B., Suzuki, Y., Nergiz, M. E., Costanzo, M., Baryshnikova, A., Giaever, G., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.71 · Cited by 315
Accelerated evolution of resistance in multidrug environments
Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805965105 · Cited by 300
Chemical combination effects predict connectivity in biological systems
Lehár, J., Zimmermann, G. R., Krueger, A. S., Molnar, R. A., Ledell, J. T., Heilbut, A. M., Short, G. F., Giusti, L. C., Nolan, G. P., Magid, O. A., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100116 · Cited by 275
Warringer, J., & Blomberg, A. (2003) · Yeast · doi:10.1002/yea.931 · Cited by 265
Potential of old-generation antibiotics to address current need for new antibiotics
Falagas, M. E., Grammatikos, A. P., & Michalopoulos, A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.593 · Cited by 247
Rifampin Combination Therapy for Nonmycobacterial Infections
Forrest, G. N., & Tamura, K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-09 · Cited by 242
Combination drugs, an emerging option for antibacterial therapy
Cottarel, G., & Wierzbowski, J. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.09.004 · Cited by 237
Die quantitativen Probleme der Pharmakologie
Loewe, S. (1928) · Ergebnisse der Physiologie · doi:10.1007/bf02322290 · Cited by 229
Nonoptimal microbial response to antibiotics underlies suppressive drug interactions
Bollenbach, T., Quan, S., Chait, R., & Kishony, R. (2009) · Cell · doi:10.1016/j.cell.2009.10.025 · Cited by 227
Topley and Wilson's Principles of Bacteriology and Immunity
(1965) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1965.tb71921.x · Cited by 203
Distinct Single-Cell Morphological Dynamics under Beta-Lactam Antibiotics
Yao, Z., Kahne, D., & Kishony, R. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.016 · Cited by 193
Cozens, R. M., Tuomanen, E., Tosch, W., Zak, O., Suter, J., & Tomasz, A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.5.797 · Cited by 169
Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo
Johansen, H., Jensen, T. G., Dessau, R. B., Lundgren, B., & Frimodt-Moller, N. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.973 · Cited by 73
Drusano, G. L., D’Argenio, D. Z., Preston, S. L., Barone, C., Symonds, W., LaFon, S. W., Rogers, M., Prince, W., Bye, A., & Bilello, J. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1655-1659.2000 · Cited by 60
Ankomah, P., Johnson, P. J., & Levin, B. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003300 · Cited by 54
Drusano, G. L., D’Argenio, D. Z., Symonds, W., Bilello, P., McDowell, J. A., Sadler, B., Bye, A., & Bilello, J. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2153 · Cited by 47
Cunha, B. A. (2004) · Infection · doi:10.1007/s15010-004-3065-5 · Cited by 13
Cited by
Unravelling the collateral damage of antibiotics on gut bacteria
Maier, L., Goemans, C. V., Wirbel, J., Kuhn, M., Eberl, C., Pruteanu, M., Müller, P., Garcia-Santamarina, S., Cacace, E., Zhang, B., et al. (2021) · Nature · doi:10.1038/s41586-021-03986-2 · Cited by 391
A White-Box Machine Learning Approach for Revealing Antibiotic Mechanisms of Action
Yang, J. H., Wright, S. N., Hamblin, M., McCloskey, D., Alcantar, M. A., Schrübbers, L., Lopatkin, A. J., Satish, S., Nili, A., Palsson, B. O., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.016 · Cited by 321
Proximate and ultimate causes of the bactericidal action of antibiotics
Baquero, F., & Levin, B. R. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00443-1 · Cited by 307
Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution
Bollenbach, T. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.05.008 · Cited by 261
Coetzee, J. F., Magstadt, D. R., Sidhu, P. K., Follett, L., Schuler, A. M., Krull, A. C., Cooper, V. L., Engelken, T. J., Kleinhenz, M. D., & O’Connor, A. M. (2019) · PLOS ONE · doi:10.1371/journal.pone.0219104 · Cited by 39
Metadata
- Authors
- Ocampo, P. S., Lázár, V., Papp, B., Arnoldini, M., Abel zur Wiesch, P., Busa-Fekete, R., Fekete, G., Pál, C., Ackermann, M., & Bonhoeffer, S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2014-08
- Volume
- 58
- Issue
- 8
- Pages
- 4573-4582
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2112396377
- Cited by
- 284
- References
- 35
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.